Yahoo Αναζήτηση Διαδυκτίου

Αποτελέσματα Αναζήτησης

1. s3-us-west-2.amazonaws.com › drugbank › cite_thisexanta (ximelagatran) tablets nda 21-686 fda advisory committee...

   s3-us-west-2.amazonaws.com › drugbank › cite_this

   approval for the use of EXANTA® (ximelagatran) Tablets as: œ An oral 24-mg twice daily (bid) fixed dose for the long-term secondary prevention of venous thromboembolism (VTE) after standard treatment for an episode of acute

2. www.fda.gov › drugs › nda-and-bla-approvalsNDA and BLA Calendar Year Approvals | FDA

   www.fda.gov › drugs › nda-and-bla-approvals

   • Αποθηκευμένο αντίγραφο

   2 Μαρ 2023 · CDER Drug and Biologic Approvals for Calendar Year 2020. CDER Drug and Biologic Approvals for Calendar Year 2019. CDER Drug and Biologic Approvals for Calendar Year 2018. CDER Drug and Biologic ...

3. www.fdatracker.com › fda-calendarFDA Calendar – FDA Tracker

   www.fdatracker.com › fda-calendar

   • Αποθηκευμένο αντίγραφο

   Our enhanced FDA calendar integrates PDUFA dates, clinical trial primary completion dates, and working capital runway estimates into a single timeline that covers companies publicly traded in the U.S. facing upcoming PDUFA dates.

4. www.fda.gov › media › 177082CY 2023 CDER Drug and Biologic Calendar Year Approvals As of...

   www.fda.gov › media › 177082

   This report reflects the data shown as it is identified in the database. Selection Criteria: User Response: Start Date: 1/1/2023 End Date: 12/31/2023. Sort Order: Approval Date.

5. www.drugs.com › history › exantaExanta (ximelagatran): What is it and is it FDA approved ... -...

   www.drugs.com › history › exanta

   • Αποθηκευμένο αντίγραφο

   Exanta FDA Approval Status. FDA Approved: No. Brand name: Exanta. Generic name: ximelagatran. Company: AstraZeneca. Treatment for: Prevention of Thromboembolism in Atrial Fibrillation.

6. biopharmawatch.com › fda-calendarFDA Calendar - BioPharmaWatch

   biopharmawatch.com › fda-calendar

   Our Free FDA Calendar is a daily updated tool that tracks future catalysts and key dates across biotech and pharma companies, including clinical trials, regulatory events, and PDUFA dates, designed to inform on stock-moving events

7. www.fda.gov › drugs › novel-drug-approvals-fdaNovel Drug Approvals for 2024 | FDA

   www.fda.gov › drugs › novel-drug-approvals-fda

   • Αποθηκευμένο αντίγραφο

   29 Ιουλ 2024 · The table below is a running list of CDER’s novel drugs approvals for 2024. Export Excel. Showing 1 to 23 of 23 entries. *The listed “FDA-approved use” on this website is for presentation...